)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Bright Minds Biosciences (DRUG) investor relations material
Bright Minds Biosciences Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary23 Dec, 2025
Executive summary
Clinical-stage biotech focused on serotonergic therapeutics for CNS disorders, with lead candidate BMB-101 in Phase 2 trials for epilepsy and Prader-Willi Syndrome, and additional preclinical programs in depression and pain.
Net loss of $12.2M for FY2025, up from $2.8M in FY2024, driven by increased R&D and operational expenses as pipeline advanced.
Raised $82.1M in equity during FY2025, including a $35M private placement and $33.5M via at-the-market (ATM) program, resulting in $82.9M cash at year-end.
Sufficient cash to fund operations for at least 12 months; no revenues generated to date.
Financial highlights
Cash and cash equivalents: $82.9M as of September 30, 2025 (up from $5.7M in 2024).
Net loss: $12.2M for FY2025 (vs. $2.8M in FY2024).
R&D expenses: $11.1M in FY2025 (vs. $1.2M in FY2024), reflecting increased clinical activity.
Weighted average shares outstanding: 6.88M (FY2025); 7.64M shares issued and outstanding at year-end.
No revenue recognized; negative operating cash flow continues.
Outlook and guidance
Plans to continue Phase 2/3 clinical development of BMB-101 in epilepsy and initiate Phase 2 in Prader-Willi Syndrome.
Preclinical candidate BMB-105 expected to enter Phase 1 studies.
May utilize ATM program for additional capital raises, subject to market conditions.
Sufficient cash for at least 12 months of operations; ongoing need for additional capital for long-term development.
Detail FY25 R&D spend allocation by program
Assess cash runway given increased R&D burn
Quantify potential impact of CMO lawsuit
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Bright Minds Biosciences earnings date
Q1 202610 Feb, 2026
Next Bright Minds Biosciences earnings date
Q1 202610 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage